The point is that its irresponsible (and frankly a bit scummy) to keep pointing to a single patient that has exceeded their survival expectation, or gone into remission, after having been treated by one of IMU's products. This is because unless you have successfully completed statistically rigorous clinical trials you can't claim that the improvement in the patient's health is a direct result of your product.
Imagine if the situation was reversed - how would Leslie like it if IMU was blamed for the deaths or disease progression of all patients that have had this happen after being treated with an IMU product?
The point is that its irresponsible (and frankly a bit scummy)...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.2¢ |
Change
-0.003(3.53%) |
Mkt cap ! $600.2M | |||
| Open | High | Low | Value | Volume |
| 8.5¢ | 8.6¢ | 8.2¢ | $1.246M | 14.84M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 446526 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 535664 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.2¢ |
Change
-0.003 ( 2.38 %) |
||||
| Open | High | Low | Volume | ||
| 8.6¢ | 8.6¢ | 8.2¢ | 4518456 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| IMU (ASX) Chart |